LALPATHLAB
NIFTY500
Dr. Lal Path Labs Ltd.
Pharma · NSE
₹1,649.80
1Y+18.6%
52-week range
₹1,273 – ₹1,762
From 52w high
-6.3%
RSI (14)
71.7
vs SMA 50 / 200
↑ 50 · ↑ 200
PE
52.2
Forward PE
40.1
ROE
21.5%
Profit margin
18.3%
D/E
7.83
Dividend yield
0.85%
Quality score
49/100
Revenue growth
16.6%
Earnings growth
-15.4%
For informational purposes only. Not investment advice. VivaTrades is not a SEBI-registered Investment Adviser or Research Analyst. Market data sourced from public feeds; consult a registered adviser before any investment decision.